See also this year's filing and all EDGAR filings for this company.
PDF Report 0001829635_2023_Transcode_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001829635, Transcode Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 7,379,405 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 208,581 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 4,347,290 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,433,448 |
| 9 | ResearchAndDevelopmentExpense | 10,232,366 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,100,846 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 7,587,986 |
| 1 | Liabilities | 4,347,290 |
| 2 | Expenses | 18,665,814 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 3,240,696 |
| 5 | NetIncome | -17,564,968 |
| 6 | ComprehensiveNetIncome | -17,564,968 |
| 7 | BaseVar | 15,850,968 |
| 8 | EconomicCapitalRatio | -2.01 |